We are live on ! Find out more
FP

Foundry Partners Portfolio holdings

AUM $1.89B
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$1.59B
AUM Growth
-$73.3M
Cap. Flow
+$12.5M
Cap. Flow %
0.79%
Top 10 Hldgs %
19.06%
Holding
339
New
37
Increased
202
Reduced
75
Closed
23

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$21.8M
2
BWA icon
BorgWarner
BWA
+$18.9M
3
HIG icon
Hartford Financial Services
HIG
+$18.6M
4
CI icon
Cigna
CI
+$15.3M
5
FOXA icon
Fox Class A
FOXA
+$11.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$25.5M
2
CNC icon
Centene
CNC
+$18.6M
3
QCOM icon
Qualcomm
QCOM
+$13.2M
4
ALLY icon
Ally Financial
ALLY
+$11.4M
5
VZ icon
Verizon
VZ
+$10.8M

Sector Composition

Rank Sector Weight
1 Financials 22.89%
2 Healthcare 13.26%
3 Industrials 11.96%
4 Energy 9.71%
5 Technology 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$918B
$37.1M 2.34%
354,946
+49,025
+16% +$5.63M
JNJ icon
2
Johnson & Johnson
JNJ
$602B
$36.6M 2.3%
223,970
-33,220
-13% -$5.62M
MRK icon
3
Merck
MRK
$310B
$34.2M 2.15%
396,875
-49,090
-11% -$4.38M
COP icon
4
ConocoPhillips
COP
$143B
$31.6M 1.99%
309,260
+2,465
+0.8% +$246K
AES icon
5
AES
AES
$10.6B
$30.6M 1.93%
1,354,652
+56,225
+4% +$1.33M
MO icon
6
Altria Group
MO
$123B
$29.2M 1.84%
722,318
+129,200
+22% +$5.64M
CVS icon
7
CVS Health
CVS
$139B
$28.9M 1.82%
303,177
+55,860
+23% +$5.53M
ELV icon
8
Elevance Health
ELV
$84.6B
$25.5M 1.61%
56,177
+425
+0.8% +$203K
SHEL icon
9
Shell
SHEL
$241B
$24.7M 1.55%
495,619
-52,375
-10% -$2.7M
KR icon
10
Kroger
KR
$35.1B
$24.3M 1.53%
554,501
-2,190
-0.4% -$104K
HBAN icon
11
Huntington Bancshares
HBAN
$36.7B
$24.2M 1.52%
1,832,840
+211,595
+13% +$2.83M
VZ icon
12
Verizon
VZ
$181B
$23.8M 1.5%
625,822
-242,775
-28% -$10.8M
CAT icon
13
Caterpillar
CAT
$412B
$21.9M 1.38%
133,257
+925
+0.7% +$169K
EXC icon
14
Exelon
EXC
$46.9B
$21.7M 1.37%
580,085
+15,565
+3% +$688K
AMP icon
15
Ameriprise Financial
AMP
$47.5B
$21.6M 1.36%
85,862
+715
+0.8% +$188K
GILD icon
16
Gilead Sciences
GILD
$161B
$21.3M 1.34%
+345,955
New +$21.8M
PRU icon
17
Prudential Financial
PRU
$41.1B
$21.3M 1.34%
248,710
+18,260
+8% +$1.76M
HII icon
18
Huntington Ingalls Industries
HII
$10.7B
$20.7M 1.31%
93,630
+10,540
+13% +$2.36M
CMCSA icon
19
Comcast
CMCSA
$84.5B
$19.6M 1.23%
667,735
+5,425
+0.8% +$203K
GS icon
20
Goldman Sachs
GS
$320B
$19.3M 1.22%
66,002
-19,922
-23% -$6.45M
EMR icon
21
Emerson Electric
EMR
$78.3B
$18.9M 1.19%
257,570
+52,650
+26% +$4.37M
HIG icon
22
Hartford Financial Services
HIG
$38.5B
$17.7M 1.12%
+286,050
New +$18.6M
EOG icon
23
EOG Resources
EOG
$76B
$17.7M 1.11%
158,425
-24,980
-14% -$2.8M
SPG icon
24
Simon Property Group
SPG
$73.9B
$17.7M 1.11%
196,685
+32,755
+20% +$3.35M
LKQ icon
25
LKQ Corp
LKQ
$6.38B
$16.8M 1.06%
355,565
-18,720
-5% -$979K
1
2 3 4 5

Similar funds

ST
Sabal Trust St. Petersburg, Florida $1.8B AUM 8.75% 1-Year Est. Return
UH
Unigestion Holding Geneva, Switzerland $1.7B AUM 9.06% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return

Foundry Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Foundry Partners held 339 positions worth $1.59B, down 4.4% from $1.66B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Foundry Partners's Q3 2022 filing shows 37 new, 202 increased, 75 reduced and 23 closed positions. Its largest new stake was Gilead Sciences: 345,955 shares worth $21.3M. The largest sale was Pfizer, an estimated $25.5M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Foundry Partners's largest Q3 2022 buy was Gilead Sciences: 345,955 shares worth $21.3M.
  • Foundry Partners added most to Altria Group in Q3 2022, an estimated $5.64M increase.
  • Foundry Partners's biggest Q3 2022 reduction was Verizon, cutting an estimated $10.8M.
  • Foundry Partners fully exited Pfizer in Q3 2022, selling an estimated $25.5M.
  • Foundry Partners's ten largest holdings make up 19% of its $1.59B portfolio in Q3 2022.
  • Foundry Partners opened 37 new positions and closed 23 in Q3 2022.
  • Foundry Partners's portfolio value fell 4.4% quarter-over-quarter to $1.59B.

Based on Foundry Partners's 13F filing for Q3 2022, filed 21 Oct 2022.